Impact of Biological Factors on Dental Implant
Launched by AL-MUSTANSIRIYAH UNIVERSITY · Sep 7, 2023
Trial Information
Current as of July 16, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of bone density respond to a treatment called Platelet Rich Fibrin (PRF) in patients who need dental implants. The researchers want to find out if the reaction of bones to PRF changes depending on their density and whether PRF helps dental implants heal faster and bond better with the bone. This is important because understanding these factors can improve dental implant success for patients.
To participate in this study, you must be a non-smoker without any serious medical conditions that could affect bone health. You should also not be taking any medications that might interfere with healing. If you qualify and choose to participate, you'll receive detailed information about the study, including your rights. PRF will be injected into the area prepared for your dental implant, and the researchers will monitor how well your bone integrates with the implant over time. Remember, you can withdraw from the study at any time if you decide it's not for you.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • Non- smoker.
- • No medical history of any systemic diseases that affect the bone metabolism.
- • Did not receive any systemic drugs.
- • Has edentulous area that needs at least two successive implants.
- The exclusion criteria were as follows:
- • Systemic disease or medication compromising bone and soft tissue healing.
- • Pathology in the edentulous region.
- • Bruxism.
- • Disease of the oral mucosa.
About Al Mustansiriyah University
Al-Mustansiriyah University is a prominent academic institution located in Baghdad, Iraq, dedicated to advancing education, research, and healthcare. As a clinical trial sponsor, the university leverages its expertise in medical and scientific research to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodologies, Al-Mustansiriyah University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and reliability of its clinical trials, ultimately striving to enhance public health and advance medical practices within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, Alkadhmiya City, Iraq
Patients applied
Trial Officials
Afya SD Al-radha, Ph. D
Principal Investigator
College of Dentistry / Mustansiriyah University, P.O. Box: 14022,Baghdad, Iraq
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported